We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

16 hedge funds and large institutions have $35.9M invested in Tenax Therapeutics in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $31.4M → $35.9M (+$4.43M)

16% less funds holding

Funds holding: 19 → 16 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.58M
2
OM
Opaleye Management
Massachusetts
+$525K
3
EGA
Eagle Global Advisors
Texas
+$105K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$246K
2
Axa
Axa
France
-$164K
3
Morgan Stanley
Morgan Stanley
New York
-$105K
4
Millennium Management
Millennium Management
New York
-$94K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$9.18M +$1.58M +15 +21%
RCM
2
RA Capital Management
Massachusetts
$8.71M – – –
BC
3
Broadfin Capital
New York
$6.42M – – –
GPP
4
Great Point Partners
Connecticut
$3.61M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.15M – – –
OM
6
Opaleye Management
Massachusetts
$1.98M +$525K +5 +36%
OPPM
7
Opus Point Partners Management
New York
$812K – – –
Deutsche Bank
8
Deutsche Bank
Germany
$471K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$409K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$262K – – –
BFA
11
BlackRock Fund Advisors
California
$211K – – –
Verition Fund Management
12
Verition Fund Management
Connecticut
$151K – – –
BIT
13
BlackRock Institutional Trust
California
$104K – – –
Northern Trust
14
Northern Trust
Illinois
$99K – – –
Goldman Sachs
15
Goldman Sachs
New York
$73K – – –
EGA
16
Eagle Global Advisors
Texas
$63K +$105K +1 New
RCM
17
Rotella Capital Management
Washington
$38K – – –
FMA
18
FNY Managed Accounts
New York
$19.6K – – –
TRCT
19
Tower Research Capital (TRC)
New York
$19K – – –
Morgan Stanley
20
Morgan Stanley
New York
$17K -$105K -1 Closed
FNYS
21
First New York Securities
New York
$14.7K – – –
BIM
22
BlackRock Investment Management
Delaware
$13K – – –
UBS Group
23
UBS Group
Switzerland
$9K – – –
RI
24
RTW Investments
New York
$8K – – –
Citigroup
25
Citigroup
New York
$7K – – –
1
2

TENX Hedge Fund Activity: Q1 2015 in Review

16 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2015, worth a combined $35.9M — up 14% from $31.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TENX and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Sabby Management, adding an estimated $1.58M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $246K sold.

  • 16 institutional investors held Tenax Therapeutics (TENX) as of Q1 2015, down from 19 in Q4 2014.
  • Funds reported $35.9M of Tenax Therapeutics stock for Q1 2015, up 14% quarter-over-quarter.
  • 1 fund opened new Tenax Therapeutics positions in Q1 2015 and 4 closed out, a net change of -3 holders.
  • The largest Tenax Therapeutics buyer in Q1 2015 was Sabby Management, an estimated $1.58M added.
  • The largest Tenax Therapeutics seller in Q1 2015 was D.E. Shaw & Co, an estimated $246K sold.

Based on aggregated 13F filings for Q1 2015.